The Validity of Surrogate Endpoints in Sub Groups of Metastatic Colorectal Cancer Patients Defined by Treatment Class and KRAS Status. (2022)

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/cancers14215391

PubMed Identifier: 36358810

Publication URI: http://europepmc.org/abstract/MED/36358810

Type: Journal Article/Review

Volume: 14

Parent Publication: Cancers

Issue: 21

ISSN: 2072-6694